We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

114 hedge funds and large institutions have $1.99B invested in Revolution Medicines in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 30

2.45% more ownership

Funds ownership: 95.81% → 98.26% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

1% less call options, than puts

Call options by funds: $1.58M | Put options by funds: $1.6M

11% less capital invested

Capital invested by funds: $2.23B → $1.99B (-$243M)

12% less funds holding

Funds holding: 130 → 114 (-16)

59% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 27

Holders
114
Holders Change
-16
Holders Change %
-12.31%
% of All Funds
2%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
11
Increased
38
Reduced
30
Closed
27
Calls
$1.58M
Puts
$1.6M
Net Calls
-$22K
Net Calls Change
-$235K

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$46.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$28.3M
4
CC
Casdin Capital
New York
+$14.4M
5
State Street
State Street
Massachusetts
+$13.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$50.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.3M
3
Morgan Stanley
Morgan Stanley
New York
-$12.4M
4
Blackstone Inc
Blackstone Inc
New York
-$11.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$5.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$15.4M -$182K -6,247 -1%
CS
27
Candriam SCA
Luxembourg
$13.5M +$2.77M +95,312 +24%
Bessemer Group
28
Bessemer Group
New Jersey
$12.1M – – –
Charles Schwab
29
Charles Schwab
California
$11.7M +$2.06M +70,898 +20%
Norges Bank
30
Norges Bank
Norway
$11.2M +$9.3M +319,400 +369%
N
31
Nuveen
North Carolina
$9.42M -$806K -27,705 -7%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$7.38M +$1.05M +35,981 +15%
CC
33
Commodore Capital
New York
$6.22M +$6.58M +226,228 New
BBA
34
Baker Bros. Advisors
New York
$6.11M – – –
DCM
35
DAFNA Capital Management
California
$5.77M – – –
Millennium Management
36
Millennium Management
New York
$5.14M +$4.22M +145,151 +347%
MB
37
MPM BioImpact
Massachusetts
$4.13M +$4.37M +150,000 New
UBS Group
38
UBS Group
Switzerland
$3.23M +$3.38M +116,252 +10,588%
Two Sigma Investments
39
Two Sigma Investments
New York
$3.12M -$244K -8,372 -7%
Swiss National Bank
40
Swiss National Bank
Switzerland
$2.9M +$61.1K +2,100 +2%
Morgan Stanley
41
Morgan Stanley
New York
$2.75M -$12.4M -426,435 -81%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$2.73M +$674K +23,162 +30%
JMPWA
43
JP Morgan Private Wealth Advisors
California
$2.73M -$134K -4,598 -4%
Citadel Advisors
44
Citadel Advisors
Florida
$2.57M -$3.04M -104,339 -53%
Deutsche Bank
45
Deutsche Bank
Germany
$2.46M -$571K -19,629 -18%
AllianceBernstein
46
AllianceBernstein
Tennessee
$2.37M +$582K +20,000 +30%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$2.22M +$75.9K +2,609 +3%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$2.11M – – –
Citigroup
49
Citigroup
New York
$2.02M -$1.43M -49,023 -40%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$2.01M +$1.3M +44,600 +157%
1
2
3 4 5

RVMD Hedge Fund Activity: Q3 2021 in Review

114 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q3 2021, worth a combined $1.99B — down 11% from $2.23B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of RVMD and 11 opened new positions — a net loss of 16 holders — while 30 trimmed existing stakes and 38 added.

The largest buyer was Bellevue Group, adding an estimated $46.7M. The largest seller was Fidelity Investments, cutting an estimated $50.5M.

  • 114 institutional investors held Revolution Medicines (RVMD) as of Q3 2021, down from 130 in Q2 2021.
  • Funds reported $1.99B of Revolution Medicines stock for Q3 2021, down 11% quarter-over-quarter.
  • 11 funds opened new Revolution Medicines positions in Q3 2021 and 27 closed out, a net change of -16 holders.
  • The largest Revolution Medicines buyer in Q3 2021 was Bellevue Group, an estimated $46.7M added.
  • The largest Revolution Medicines seller in Q3 2021 was Fidelity Investments, an estimated $50.5M sold.

Based on aggregated 13F filings for Q3 2021.